Literature DB >> 15663753

The new arteriovenous fistula: the need for earlier evaluation and intervention.

Kaveh Kian, Joseph A Vassalotti.   

Abstract

The National Kidney Foundation's Dialysis Outcomes Quality Initiative recommends an ideal 3- to 4-month arteriovenous fistula (AVF) maturation period prior to cannulation. This recommendation may be misinterpreted by practicing nephrologists to mean that they should wait 3 months before performing a clinical assessment of the AVF. Such a delay in evaluating AVF maturity results in unnecessarily prolonged catheter use in dialysis patients whose ultimately unsatisfactory fistula could already have been diagnosed and modified at a much earlier point. Clinical assessment at 1 month can detect the common etiologies for nonmaturity, including stenosis in the vein adjacent to the anastomosis and accessory vein diversion of flow from the main fistula vein. Duplex ultrasound provides additional information in selected cases. Early evaluation allows for early fistulography for problems and potentially early cannulation for adequately maturing fistulas. Prospective trials of early AVF clinical assessment at 1 month should be performed.

Entities:  

Mesh:

Year:  2005        PMID: 15663753     DOI: 10.1111/j.1525-139X.2005.18114.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  3 in total

1.  Arteriovenous fistulas as vascular access for hemodialysis: The preliminary experience at the University Hospital of the West Indies, Jamaica.

Authors:  Shamir O Cawich; Hilary Brown; Allie Martin; Mark S Newnham; Rageev Venugopal; Eric Williams
Journal:  Int J Angiol       Date:  2009

2. 

Authors:  Rohan Arasu; Dev Jegatheesan; Yogeesan Sivakumaran
Journal:  Can Fam Physician       Date:  2022-08       Impact factor: 3.025

Review 3.  Overview of hemodialysis access and assessment.

Authors:  Rohan Arasu; Dev Jegatheesan; Yogeesan Sivakumaran
Journal:  Can Fam Physician       Date:  2022-08       Impact factor: 3.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.